Add to ORKG5th International Meeting on Metabotropic Glutamate Receptors, Taormina, ITALY, SEP 18-23, 2005International audienceno abstrac
Metabotropic glutamate (mGlu) receptors are G protein-coupled receptors expressed primarily on neuro...
In recent years there have been tremendous advances in our understanding of the circuitry of the bas...
12th Biennial Meeting of the European-Pharmacology-Society, Tubingen, GERMANY, AUG 31-SEP 03, 2007In...
6th International mGluR Meeting, Taormina, ITALY, SEP 14-19, 2008International audienceno abstrac
12th Biennial Meeting of the European-Pharmacology-Society, Tubingen, GERMANY, AUG 31-SEP 03, 2007In...
International audienceThe interplay between dopamine and glutamate in the basal ganglia regulate cri...
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopamin...
10th Biennial Meeting of the European-Behavioural-Pharmacology-Society, ANTWERP, BELGIUM, SEP 06-09,...
Parkinson's disease is the slow-progressing chronic neurodegenerative disease. It caused by the prog...
10th Biennial Meeting of the European-Behavioural-Pharmacology-Society, ANTWERP, BELGIUM, SEP 06-09,...
11th Biennial Meeting of the European-Behavioral-Pharmacology-Society, Barcelona, SPAIN, SEP 09-12, ...
In the early sixties, anticholinergic drugs were introduced in the pharmacological treatment of Park...
Parkinson’s disease is characterized by the degeneration of dopaminergic neurons of the substantia n...
Parkinson's disease (PD) is characterized by progressive degeneration of dopaminergic neurons of the...
Metabotropic glutamate (mGlu) receptors are a large, heterogeneous family of G-protein coupled recep...
Metabotropic glutamate (mGlu) receptors are G protein-coupled receptors expressed primarily on neuro...
In recent years there have been tremendous advances in our understanding of the circuitry of the bas...
12th Biennial Meeting of the European-Pharmacology-Society, Tubingen, GERMANY, AUG 31-SEP 03, 2007In...
6th International mGluR Meeting, Taormina, ITALY, SEP 14-19, 2008International audienceno abstrac
12th Biennial Meeting of the European-Pharmacology-Society, Tubingen, GERMANY, AUG 31-SEP 03, 2007In...
International audienceThe interplay between dopamine and glutamate in the basal ganglia regulate cri...
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopamin...
10th Biennial Meeting of the European-Behavioural-Pharmacology-Society, ANTWERP, BELGIUM, SEP 06-09,...
Parkinson's disease is the slow-progressing chronic neurodegenerative disease. It caused by the prog...
10th Biennial Meeting of the European-Behavioural-Pharmacology-Society, ANTWERP, BELGIUM, SEP 06-09,...
11th Biennial Meeting of the European-Behavioral-Pharmacology-Society, Barcelona, SPAIN, SEP 09-12, ...
In the early sixties, anticholinergic drugs were introduced in the pharmacological treatment of Park...
Parkinson’s disease is characterized by the degeneration of dopaminergic neurons of the substantia n...
Parkinson's disease (PD) is characterized by progressive degeneration of dopaminergic neurons of the...
Metabotropic glutamate (mGlu) receptors are a large, heterogeneous family of G-protein coupled recep...
Metabotropic glutamate (mGlu) receptors are G protein-coupled receptors expressed primarily on neuro...
In recent years there have been tremendous advances in our understanding of the circuitry of the bas...
12th Biennial Meeting of the European-Pharmacology-Society, Tubingen, GERMANY, AUG 31-SEP 03, 2007In...